We report a case of chronic lymphocytic leukemia (CLL) in a pregnant female. The patient, a healthy 22-year-old, G4P3 female, presented to our institution for a routine prenatal visit at 35 weeks gestation and a routine peripheral complete blood count (CBC) was performed. The CBC showed a white blood cell count (WBC) of 45 400/l with 82% lymphocytes. The patient denied any recent illness or symptoms such as fever, night sweats, or weight loss. Physical examination revealed a gravid uterus, but no adenopathy. A review of the peripheral blood smear showed a lymphocytosis consisting of mature lymphocytes with slightly enlarged, slightly irregular nuclei, with a coarse, 'clumped' chromatin pattern. Nucleoli were not apparent. Flow cytometry performed on the peripheral blood showed co-expression (in 60% of the cells) of CD5 and CD19. In addition, 54% of the cells were weakly positive for surface lambda, while 1% were weakly positive for surface kappa. In a separate flow cytometry run several months later on peripheral blood stored at −120°C, the cells showed monoclonality (96% expressed weak lambda, with 0% kappa), and CD23 expression (84% cells positive). The presence of CD10 was not tested. Cytogenetic studies on peripheral blood, using phytohemagglutinin/interleukin-2 stimulated cells, demonstrated a normal female karyotype.
markedly decreased following delivery. While the CLL remained (as evidenced by a continued high percentage of monoclonal lymphocytes), the absolute number of monoclonal lymphocytes decreased. This represents an apparent spontaneous 'clinical' (but not 'clonal') regression. Interestingly, a decrease in the patient's WBC occurred in the case reported by Chrisomalis. Published reports of such regression of CLL in any patient are rare. There have been approximately 30 cases of spontaneous regression of CLL, but many of these cases involved some type of therapy, and other cases eventually relapsed. 6 The reason for the decrease in WBC following delivery in this current case is not clear, but may involve an increase in immunotolerance during pregnancy that allowed the expansion of a monoclonal population of B-lymphocytes. The patient may have returned to her normal state of immunity following delivery, and the monoclonal population, while still present, decreased in number. Sex hormones have been hypothetically involved in the regulation of the immune system. Rheumatoid arthritis has been shown to decrease in severity during pregnancy and it is possible that pregnancy-induced changes in sex hormones are involved. 7 It is possible that sex hormone changes following delivery may play a role in spontaneous regression of CLL. Other hypothetical mechanisms of spontaneous regression involve viral destruction of tumor cells, or viral-induced host immune defense mechanisms (production of interferon and other cytokines). 6 The prognosis for young patients with CLL is significantly better than older patients. 1, 8 In addition, patients with Rai stage 0 (bone marrow involvement and lymphocytosis only) have a median survival greater than 120 months. Intuitively, any CLL patient with a WBC that is apparently returning to normal can be considered to have a better prognosis than a CLL patient with an increasing WBC. Taken together, the patient discussed above can be expected to survive many years. No treatment has been initiated, though the patient and her siblings will be HLA typed to determine if a comparable bone marrow donor is available.
